Last update :
19/04/2021
References   References 4498  
Type : Journal

Research teams : Paris - Hôpital Robert Debré, Service pharmacie
Authors : Hausherr A, Roessle C, Pinet E, Vasseur V, Abarou T, Benakouche S, Bourdon O, Storme T.
Title : Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/mL ursodesoxycholic acid for newborns.
Reference : Pharmaceutical Technology in Hospital Pharmacy 2020

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
Oral solutionUrsodesoxycholique acid Various
Stability in solutions Glass Powder 5000 mg
® = ?
Inorpha® 100 mL
Xanthan gum 0,25% 250 mg
2-6°C Protect from light
90 Day
Stability in solutions Glass Powder 5000 mg
® = ?
Inorpha® 100 mL
Xanthan gum 0,25% 250 mg
20-24°C Protect from light
60 Day

  Mentions Légales